… of several types of severe cutaneous adverse reactions (SCAR) such as Stevens–Johnson
syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reactions with eosinophilia and …

… This has become apparent in the event of severe cutaneous adverse reactions (SCARs),
which can be life-threatening. In this review, four hypotheses were identified to describe how …

… for DPH-induced skin reactions. Therefore, … adverse reactions. However, the small sample
size in this study indicates that further studies on patients with DPH-induced skin reactions are …

… symptoms (DRESS) are considered Severe Cutaneous Adverse Reactions (SCARs). SJS …
:02, which has been strongly associated with serious skin reactions, in ancestry across broad …

… included “cytochrome P450 2C9” OR “CYP2C9” AND “phenytoin” AND “Stevens-Johnson
syndrome” OR “toxic epidermal necrolysis” OR “severe cutaneous adverse reactions.” There …

… with severe adverse events or greatly enhanced effects and … most severe cases of adverse
events or exaggerated effects … adverse effects will not be cost-effective unless the toxicity is …

… However, studies have not highlighted the importance of other genetic polymorphisms in
dapsone-induced severe cutaneous adverse reactions (SCAR). We investigated the …

… as severe cutaneous adverse drug reactions (SCAR). The immune mechanism of SCAR is
classified as type-IV hypersensitivity reaction … drugs and severe cutaneous adverse reactions (…

… Severe cutaneous adverse reactions (SCARs), previously thought to be idiosyncratic or
unpredictable, are a deadly form of adverse drug reactions with skin manifestations. Current …

… a high risk for severe cutaneous reactions. Upon metabolism by … a high risk of severe cutaneous
adverse reactions, especially … P450 2C9, 2C18 and 2E1 did not produce any detectable …